Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorma Isola

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
American Journal of Clinical Pathology|March 18, 2009
Chromogenic in situ hybridization is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendationsYun Gong, William Sweet, Yi-Jing Duh, et al.
Breast Cancer Research and Treatment|August 21, 2002
Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testingDavid Gancberg, Tero Järvinen, Angelo di Leo, et al.
International Journal of Molecular Sciences|July 14, 2023
The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug TreatmentJorma Isola, Markku Mäki, Martin Hils, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 2002
Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesisEberhard Korsching, Jens Packeisen, Konstantin Agelopoulos, et al.
The Journal of Pathology|April 20, 2004
Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer studyHorst Buerger, Jens Packeisen, Almuth Boecker, et al.
Cancer Genetics and Cytogenetics|January 11, 2007
Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1Karin Rennstam, Göran Jönsson, Minna Tanner, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 4, 2020
Genome-Wide Transcriptomic Analysis of Intestinal Mucosa in Celiac Disease Patients on a Gluten-Free Diet and Postgluten ChallengeValeriia Dotsenko, Mikko Oittinen, Juha Taavela, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based studyHeikki Joensuu, Jorma Isola, Mikael Lundin, et al.
BMC Gastroenterology|November 16, 2019
Histological, immunohistochemical and mRNA gene expression responses in coeliac disease patients challenged with gluten using PAXgene fixed paraffin-embedded duodenal biopsiesJuha Taavela, Keijo Viiri, Alina Popp, et al.
International Journal of Cancer|February 22, 2002
Cancer incidence in families with multiple glioma patientsNiina Paunu, Eero Pukkala, Pekka Laippala, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
American Journal of Clinical Pathology|March 18, 2009
Chromogenic in situ hybridization is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendationsYun Gong, William Sweet, Yi-Jing Duh, et al.
Breast Cancer Research and Treatment|August 21, 2002
Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testingDavid Gancberg, Tero Järvinen, Angelo di Leo, et al.
International Journal of Molecular Sciences|July 14, 2023
The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug TreatmentJorma Isola, Markku Mäki, Martin Hils, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 2002
Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesisEberhard Korsching, Jens Packeisen, Konstantin Agelopoulos, et al.
The Journal of Pathology|April 20, 2004
Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer studyHorst Buerger, Jens Packeisen, Almuth Boecker, et al.
Cancer Genetics and Cytogenetics|January 11, 2007
Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1Karin Rennstam, Göran Jönsson, Minna Tanner, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 4, 2020
Genome-Wide Transcriptomic Analysis of Intestinal Mucosa in Celiac Disease Patients on a Gluten-Free Diet and Postgluten ChallengeValeriia Dotsenko, Mikko Oittinen, Juha Taavela, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based studyHeikki Joensuu, Jorma Isola, Mikael Lundin, et al.
BMC Gastroenterology|November 16, 2019
Histological, immunohistochemical and mRNA gene expression responses in coeliac disease patients challenged with gluten using PAXgene fixed paraffin-embedded duodenal biopsiesJuha Taavela, Keijo Viiri, Alina Popp, et al.
International Journal of Cancer|February 22, 2002
Cancer incidence in families with multiple glioma patientsNiina Paunu, Eero Pukkala, Pekka Laippala, et al.
Pageof 15